Clinical Trial Update: A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two batches of subcutaneous dasiglucagon in adults with type 1 diabetes to assess efficacy and safety for hypoglycemia management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• dasiglucagon (dasiglucagon)

Snippet

Sponsor: Zealand Pharma | Conditions: Hypoglycemia, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED